Expression of γ-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response primary cisplatin- based chemotherapy

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 2, 1998, Pages 363-367

  Hanigan, M H ^a   Frierson H F , Jr ^a   Taylor P T , Jr ^a   Gallup, D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cisplatin; Nephrotoxicity; Ototoxicity; Glutamyl transpeptidase

Indexed keywords

9 AMINOCAMPTOTHECIN; ALTRETAMINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GAMMA GLUTAMYLTRANSFERASE; IFOSFAMIDE; MELPHALAN; PACLITAXEL; TAMOXIFEN; TOPOTECAN; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEPHROTOXICITY; OTOTOXICITY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031718578     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70365-5     Document Type: Conference Paper

References (18)

1. SL Parker T Tong S Bolden PA. Wingo Cancer statistics, 1997 CA Cancer J Clin 47 1997 5 27
2. EE Partridge JL Phillips HR. Menck The National Cancer Data Base report on ovarian cancer treatment in United States Hospitals Cancer 78 1996 2236 2246
3. RL. Comis Cisplatin: the future Semin Oncol 21 1994 109 113
4. MH Hanigan BC Gallagher PT Taylor Jr MK. Large Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity Cancer Res 54 1994 5925 5929
5. MH Hanigan HF Frierson Jr. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue J Histochem Cytochem 44 1996 1101 1108
6. W Dekant S Vamvakas MW. Anders Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway MW Anders W Dekant Advances in pharmacology. Vol 27 1995 Academic Press New York 115 162
7. MH Hanigan HF Frierson Jr JE Brown MA Lovell PT. Taylor Human ovarian tumors express gamma-glutamyl transpeptidase Cancer Res 54 1994 286 290
8. American Joint Committee on Cancer Handbook for staging of cancer 1993 JB Lippincott Philadelphia
9. SA. Glantz Primer of bio-statistics 1992 McGraw-Hill New York
10. ML O’Brien KD Tew Glutathione and related enzymes in multidrug resistance Eur J Cancer 32A 1996 967 978
11. CP Schroder AK Godwin PJ O’Dwyer KD Tew TC Hamilton RF Ozols Glutathione and drug resistance Cancer Invest 14 1996 158 168
12. A Meister ME. Anderson Glutathione Annu Rev Biochem 52 1983 711 760
13. MH Hanigan WA. Ricketts Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase Biochemistry 32 1993 6302 6306
14. MH. Hanigan Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine Carcinogenesis 16 1995 181 185
15. DB Zamble SJ. Lippard Cisplatin and DNA repair in cancer chemotherapy TIBS 20 1995 435 439
16. MH Hanigan HF Frierson Jr JE Brown MA Lovell PT Taylor Human ovarian tumors express γ-glutamyl transpeptidase Cancer Res 54 1994 286 290
17. DH Kern LM. Weisenthal Highly specific prediction of antineoplastic drug resistance with an in vitro drug assay using suprapharmacologic drug exposures J Natl Cancer Inst 82 1990 582 588
18. JP Fruehauf A. Manetta Use of the extreme drug resistance assay to evaluate mechanisms of resistance in ovarian cancer: taxol resistance and MDR-1 expression Contrib Gynecol Obstet 19 1994 39 52